# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-115504
Filing Date
2023-04-25
Accepted
2023-04-25 17:06:53
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | d439021ddefa14a.htm | DEFA14A | 12345
2 | GRAPHIC | g439021g07v28.jpg | GRAPHIC | 375378
3 | GRAPHIC | g439021g93z07.jpg | GRAPHIC | 414170
| Complete submission text file | 0001193125-23-115504.txt |  | 1101289

Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33038 | Film No.: 23845747
SIC: 2834 Pharmaceutical Preparations